-
Question 1
Correct
-
You are assessing a 50-year-old man who has been diagnosed with Barrett's oesophagus following difficult to control symptoms. Biopsies did not reveal any dysplasia. What is the most strongly linked risk factor modification for the development of Barrett's oesophagus?
Your Answer: Gastro-oesophageal reflux disease
Explanation:Barrett’s oesophagus is most strongly associated with the presence of GORD as a risk factor.
Understanding Barrett’s Oesophagus
Barrett’s oesophagus is a condition where the lower oesophageal mucosa is replaced by columnar epithelium, increasing the risk of oesophageal adenocarcinoma by 50-100 fold. It is typically identified during an endoscopy for upper gastrointestinal symptoms such as dyspepsia. The length of the affected segment correlates strongly with the chances of identifying metaplasia, with the overall prevalence estimated to be around 1 in 20. Risk factors include gastro-oesophageal reflux disease (GORD), male gender, smoking, and central obesity. Interestingly, alcohol does not seem to be an independent risk factor for Barrett’s. Management includes high-dose proton pump inhibitors and endoscopic surveillance with biopsies every 3-5 years for patients with metaplasia. If dysplasia of any grade is identified, endoscopic intervention such as radiofrequency ablation or endoscopic mucosal resection is offered.
Barrett’s oesophagus is a condition where the lower oesophageal mucosa is replaced by columnar epithelium, increasing the risk of oesophageal adenocarcinoma. It is typically identified during an endoscopy for upper gastrointestinal symptoms such as dyspepsia. The length of the affected segment correlates strongly with the chances of identifying metaplasia, with the overall prevalence estimated to be around 1 in 20. Risk factors include GORD, male gender, smoking, and central obesity. Interestingly, alcohol does not seem to be an independent risk factor for Barrett’s. Management includes high-dose proton pump inhibitors and endoscopic surveillance with biopsies every 3-5 years for patients with metaplasia. If dysplasia of any grade is identified, endoscopic intervention such as radiofrequency ablation or endoscopic mucosal resection is offered.
-
This question is part of the following fields:
- Gastroenterology/Nutrition
-
-
Question 2
Correct
-
A 54 year old woman presents to the General Practice clinic with complaints of increasing dyspepsia, dysphagia, and fatigue. She reports a prolonged history of dark brown stools, but denies any recent episodes of fresh blood. She has not experienced any unexplained weight loss and underwent surgery for a peptic ulcer a decade ago. Upon investigation, she is found to have H. pylori. What should be the subsequent course of action?
Your Answer: 2 week referral to endoscopy
Explanation:Management of Dyspepsia and Referral for Possible Cancer
Dyspepsia is a common symptom that can be caused by various factors, including medication and lifestyle choices. However, it can also be a sign of underlying conditions such as stomach or oesophageal cancer. The 2015 NICE guidelines provide updated advice on when urgent referral for endoscopy is necessary. Patients with dysphagia or an upper abdominal mass consistent with stomach cancer should be referred urgently. Patients aged 55 years or older with weight loss and upper abdominal pain, reflux, or dyspepsia should also be referred urgently. Non-urgent referrals include patients with haematemesis or those with treatment-resistant dyspepsia, upper abdominal pain with low haemoglobin levels, or raised platelet count with other symptoms.
For patients with undiagnosed dyspepsia, a step-wise approach is recommended. First, medications should be reviewed for possible causes. Lifestyle advice should also be given. If symptoms persist, a trial of full-dose proton pump inhibitor for one month or a ‘test and treat’ approach for H. pylori can be tried. If symptoms persist after either approach, the alternative should be attempted. Testing for H. pylori infection can be done using a carbon-13 urea breath test, stool antigen test, or laboratory-based serology. If symptoms resolve following test and treat, there is no need to check for H. pylori eradication. However, if repeat testing is required, a carbon-13 urea breath test should be used.
-
This question is part of the following fields:
- Gastroenterology/Nutrition
-
-
Question 3
Correct
-
A 65-year-old male visits the clinic with watery diarrhoea. He was recently treated with triple therapy for a duodenal ulcer and has a medical history of GORD, bipolar syndrome, and a previous heart attack. What factor in his medical history increases his susceptibility to a Clostridium difficile infection (CDI)?
Your Answer: Omeprazole use
Explanation:C. difficile infection (CDI) is caused by disruptions in the normal gut flora, which leads to increased colonization of C. difficile and the release of toxins that cause inflammation. Established risk factors for CDI include the use of antibiotics, protein pump inhibitors, antidepressants, and conditions that affect the immune system or decrease gastric acid secretion. Bowel and early emergency surgery have also been associated with higher rates of CDI, while there is no established link between CDI and extraintestinal surgery. GORD, T2DM, and lithium are not specifically linked to higher rates of CDI, but obesity, which can be linked to many conditions and medications, is a known risk factor. Interestingly, studies have shown that statins may have a protective effect against CDI, possibly through alterations in the microbiota or reduction of inflammation in endothelial cells.
Clostridioides difficile is a type of bacteria that is commonly found in hospitals. It is a Gram positive rod that produces an exotoxin which can cause damage to the intestines, leading to a condition called pseudomembranous colitis. This bacteria usually develops when the normal gut flora is suppressed by broad-spectrum antibiotics, with second and third generation cephalosporins being the leading cause of C. difficile. Other risk factors include proton pump inhibitors. Symptoms of C. difficile include diarrhea, abdominal pain, and a raised white blood cell count. The severity of the infection can be determined using the Public Health England severity scale, which ranges from mild to life-threatening.
To diagnose C. difficile, a stool sample is tested for the presence of C. difficile toxin (CDT). Treatment for a first episode of C. difficile infection typically involves oral vancomycin for 10 days, with fidaxomicin or a combination of oral vancomycin and IV metronidazole being used as second and third-line therapies. Recurrent infections occur in around 20% of patients, increasing to 50% after their second episode. In such cases, oral fidaxomicin is recommended within 12 weeks of symptom resolution, while oral vancomycin or fidaxomicin can be used after 12 weeks. For life-threatening C. difficile infections, oral vancomycin and IV metronidazole are used, and surgery may be considered with specialist advice. Other therapies, such as bezlotoxumab and fecal microbiota transplant, may also be considered for preventing recurrences in certain cases.
-
This question is part of the following fields:
- Gastroenterology/Nutrition
-
-
Question 4
Incorrect
-
A 45-year-old woman, with a history of gallstones, arrives at the emergency department complaining of central abdominal pain that radiates to her back. Upon conducting blood tests, you observe the following result:
Amylase 480 U/L (30 - 110). The patient is diagnosed with acute pancreatitis and inquires about the severity of her condition. What is the primary factor in determining the clinical severity of acute pancreatitis?Your Answer: Presence of pancreatic calcification on an abdominal CT scan
Correct Answer: Presence of any systemic or local complications
Explanation:When determining the severity of pancreatitis, the presence of systemic or local complications is the most important factor to consider. Mild acute pancreatitis is characterized by the absence of both organ failure and local complications. Local complications in severe cases may include peripancreatic fluid collections, pancreatic or peripancreatic necrosis, pseudocysts, and walled-off areas of necrosis. The Atlanta classification system categorizes acute pancreatitis as mild, moderate, or severe. Mild cases have no organ failure, local or systemic complications, and typically resolve within a week. Pain level and initial CRP levels are not used to classify severity, but a high white blood cell count may indicate an increased risk of severe pancreatitis. Serum amylase levels and pancreatic calcification on CT scans are also not reliable indicators of severity.
Managing Acute Pancreatitis in a Hospital Setting
Acute pancreatitis is a serious condition that requires management in a hospital setting. The severity of the condition can be stratified based on the presence of organ failure and local complications. Key aspects of care include fluid resuscitation, aggressive early hydration with crystalloids, and adequate pain management with intravenous opioids. Patients should not be made ‘nil-by-mouth’ unless there is a clear reason, and enteral nutrition should be offered within 72 hours of presentation. Antibiotics should not be used prophylactically, but may be indicated in cases of infected pancreatic necrosis. Surgery may be necessary for patients with acute pancreatitis due to gallstones or obstructed biliary systems, and those with infected necrosis may require radiological drainage or surgical necrosectomy.
-
This question is part of the following fields:
- Gastroenterology/Nutrition
-
-
Question 5
Correct
-
A 32-year-old woman presents to her General Practitioner complaining of occasional abdominal distension and bloating, which varies with her menstrual cycle and is accompanied by episodes of constipation. She works as a teacher and finds work stressful; she has previously taken a course of sertraline for depression/anxiety. On examination, bloods and colonoscopy are normal.
Which of the following is the most probable diagnosis?Your Answer: Irritable bowel syndrome (IBS)
Explanation:Irritable bowel syndrome (IBS) is a gastrointestinal disorder that causes abdominal pain, bloating, and changes in bowel habits without any identifiable organic pathology. It is more common in women and can be worsened by stress and the perimenstrual period. Diagnosis is made by ruling out other potential causes of symptoms. Management includes dietary changes, such as increasing fiber intake and avoiding trigger foods, as well as psychological support. Medications may also be used to alleviate symptoms. This patient’s symptoms are not consistent with chronic pancreatitis, ulcerative colitis, peptic ulcer disease, or diverticulitis.
-
This question is part of the following fields:
- Gastroenterology/Nutrition
-
-
Question 6
Incorrect
-
A 76-year-old man comes to the emergency department complaining of severe abdominal pain. He reports not having had a bowel movement or passed gas in the past 48 hours. Upon further questioning, he reveals that he has experienced constipation and weight loss in recent weeks. After a CT scan, a mass is discovered in the hepatic flexure, leading the medical team to suspect a large bowel obstruction caused by cancer. What is the most suitable surgical treatment plan for this patient?
Your Answer: High anterior resection
Correct Answer: Right hemicolectomy
Explanation:The appropriate surgical procedure for a patient with caecal, ascending or proximal transverse colon cancer is a right hemicolectomy. This involves removing the cecum, ascending colon, and proximal third of the transverse colon. If the cancer is located at the hepatic flexure, an extended right hemicolectomy may be necessary. Hartmann’s procedure is reserved for emergencies such as bowel obstruction or perforation and involves complete resection of the rectum and sigmoid colon with the formation of an end colostomy. A high anterior resection is used for upper rectal tumors, while a left hemicolectomy is used for distal two-thirds of the transverse colon and descending colon tumors. A low anterior resection is used for low rectal tumors, but none of these procedures are appropriate for a patient with a mass in the hepatic flexure.
Colorectal cancer is typically diagnosed through CT scans and colonoscopies or CT colonography. Patients with tumors below the peritoneal reflection should also undergo MRI to evaluate their mesorectum. Once staging is complete, a treatment plan is formulated by a dedicated colorectal MDT meeting.
For colon cancer, surgery is the primary treatment option, with resectional surgery being the only cure. The procedure is tailored to the patient and tumor location, with lymphatic chains being resected based on arterial supply. Anastomosis is the preferred method of restoring continuity, but in some cases, an end stoma may be necessary. Chemotherapy is often offered to patients with risk factors for disease recurrence.
Rectal cancer management differs from colon cancer due to the rectum’s anatomical location. Tumors can be surgically resected with either an anterior resection or an abdomino-perineal excision of rectum (APER). A meticulous dissection of the mesorectal fat and lymph nodes is integral to the procedure. Neoadjuvant radiotherapy is often offered to patients prior to resectional surgery, and those with obstructing rectal cancer should have a defunctioning loop colostomy.
Segmental resections based on blood supply and lymphatic drainage are the primary operations for cancer. The type of resection and anastomosis depend on the site of cancer. In emergency situations where the bowel has perforated, an end colostomy is often safer. Left-sided resections are more risky, but ileo-colic anastomoses are relatively safe even in the emergency setting and do not need to be defunctioned.
-
This question is part of the following fields:
- Gastroenterology/Nutrition
-
-
Question 7
Correct
-
A 30-year-old woman presents with chronic diarrhoea. She says that her stools float and are difficult to flush away.
Investigations reveal the following:
Investigation Result Normal value
Potassium (K+) 3.1 mmol/l 3.5–5.0 mmol/l
Corrected calcium (Ca2+) 2.08 mmol/l 2.20–2.60 mmol/l
Albumin 29 g/l 35–55 g/l
Haemoglobin (Hb) 91 g/l 115–155 g/l
Mean corpuscular volume (MCV) 89 fl 76–98 fl
Coeliac disease is suspected.
Which of the following is the initial investigation of choice?Your Answer: Anti-tissue transglutaminase (anti-TTG)
Explanation:Diagnosis and Investigation of Coeliac Disease
Coeliac disease is a possible diagnosis in patients presenting with chronic diarrhoea and steatorrhoea. The initial investigation of choice is the anti-tissue transglutaminase (anti-TTG) test, which has a sensitivity of over 96%. However, it is important to check immunoglobulin A (IgA) levels concurrently, as anti-TTG is an IgA antibody and may not be raised in the presence of IgA deficiency.
The treatment of choice for coeliac disease is a lifelong gluten-free diet, avoiding gluten-containing foods such as wheat, barley, rye, and oats. Patients with coeliac disease are at increased risk of small bowel lymphoma and oesophageal carcinoma over the long term.
While faecal fat estimation may be useful in estimating steatorrhoea, small bowel biopsy is the gold standard investigation for coeliac disease. However, this would not be the initial investigation of choice as it is invasive. An anti-TTG test is more sensitive and specific than an anti-gliadin test in untreated coeliac disease. Magnesium (Mg2+) levels may be abnormal in coeliac disease, but this would not be diagnostic and therefore not the first investigation of choice.
In summary, the diagnosis of coeliac disease requires a combination of clinical presentation, laboratory investigations, and small bowel biopsy if necessary. The anti-TTG test is the initial investigation of choice, and a gluten-free diet is the treatment of choice.
-
This question is part of the following fields:
- Gastroenterology/Nutrition
-
-
Question 8
Correct
-
What is the most frequent reason for hepatocellular carcinoma in the UK, particularly among older adults?
Your Answer: Hepatitis C
Explanation:Hepatocellular carcinoma is primarily caused by hepatitis B worldwide, while in Europe, hepatitis C is the most common cause.
Hepatocellular carcinoma (HCC) is a type of cancer that ranks as the third most common cause of cancer worldwide. The leading cause of HCC globally is chronic hepatitis B, while chronic hepatitis C is the most common cause in Europe. The primary risk factor for developing HCC is liver cirrhosis, which can result from various factors such as hepatitis B and C, alcohol, haemochromatosis, and primary biliary cirrhosis. Other risk factors include alpha-1 antitrypsin deficiency, hereditary tyrosinosis, glycogen storage disease, aflatoxin, certain drugs, porphyria cutanea tarda, male sex, diabetes mellitus, and metabolic syndrome.
HCC tends to present late, and patients may exhibit features of liver cirrhosis or failure such as jaundice, ascites, RUQ pain, hepatomegaly, pruritus, and splenomegaly. In some cases, decompensation may occur in patients with chronic liver disease. Raised AFP levels are also common. Screening with ultrasound and alpha-fetoprotein may be necessary for high-risk groups, including patients with liver cirrhosis secondary to hepatitis B and C or haemochromatosis, and men with liver cirrhosis secondary to alcohol.
Management options for early-stage HCC include surgical resection, liver transplantation, radiofrequency ablation, transarterial chemoembolisation, and sorafenib, a multikinase inhibitor. It is important to note that Wilson’s disease is an exception to the typical causes of liver cirrhosis and HCC.
-
This question is part of the following fields:
- Gastroenterology/Nutrition
-
-
Question 9
Correct
-
A 16-year-old male is being evaluated for iron-deficiency anemia and is discovered to have multiple polyps in his jejunum. During the examination, pigmented lesions are observed on his palms and soles. What is the probable diagnosis?
Your Answer: Peutz-Jeghers syndrome
Explanation:Understanding Peutz-Jeghers Syndrome
Peutz-Jeghers syndrome is a genetic condition that is inherited in an autosomal dominant manner. It is characterized by the presence of numerous hamartomatous polyps in the gastrointestinal tract, particularly in the small bowel. These polyps are benign, but they can cause complications such as small bowel obstruction and gastrointestinal bleeding. In addition to the polyps, individuals with Peutz-Jeghers syndrome also have pigmented freckles on their lips, face, palms, and soles.
The responsible gene for Peutz-Jeghers syndrome encodes a serine threonine kinase called LKB1 or STK11. This gene is involved in regulating cell growth and division, and mutations in this gene can lead to the development of polyps in the gastrointestinal tract.
Management of Peutz-Jeghers syndrome is typically conservative, unless complications such as obstruction or bleeding develop. Regular monitoring and surveillance of the gastrointestinal tract is recommended to detect any potential malignancies, as individuals with Peutz-Jeghers syndrome have an increased risk of developing other gastrointestinal tract cancers. Overall, early detection and management of complications can improve outcomes for individuals with Peutz-Jeghers syndrome.
-
This question is part of the following fields:
- Gastroenterology/Nutrition
-
-
Question 10
Correct
-
A 24-year-old woman presents to the emergency department with a 3-day history of vomiting. She is unable to take any fluids orally and complains of feeling dizzy and lethargic. There is no past medical history of note and she takes no regular medications. She is 12 weeks pregnant.
On examination, she has a temperature of 36.5ºC with a heart rate of 110 beats/min and a blood pressure of 100/60 mmHg. She has dry mucous membranes. Her abdomen is soft and nontender.
What is the most appropriate initial anti-emetic for this patient, given the likely diagnosis?Your Answer: Cyclizine
Explanation:Antihistamines, specifically cyclizine, are the recommended first-line treatment for nausea and vomiting in pregnancy, including hyperemesis gravidarum. Dexamethasone is not typically used for hyperemesis gravidarum, as it is more commonly used for post-operative and chemotherapy-induced nausea and vomiting. Domperidone is not commonly used for hyperemesis gravidarum, as it is primarily used to treat nausea in patients with Parkinson’s disease. Metoclopramide is a second-line treatment option for hyperemesis gravidarum, but is not the first-line choice.
Hyperemesis gravidarum is an extreme form of nausea and vomiting of pregnancy that occurs in around 1% of pregnancies and is most common between 8 and 12 weeks. It is associated with raised beta hCG levels and can be caused by multiple pregnancies, trophoblastic disease, hyperthyroidism, nulliparity, and obesity. Referral criteria for nausea and vomiting in pregnancy include continued symptoms with ketonuria and/or weight loss, a confirmed or suspected comorbidity, and inability to keep down liquids or oral antiemetics. The diagnosis of hyperemesis gravidarum requires the presence of 5% pre-pregnancy weight loss, dehydration, and electrolyte imbalance. Management includes first-line use of antihistamines and oral cyclizine or promethazine, with second-line options of ondansetron and metoclopramide. Admission may be needed for IV hydration. Complications can include Wernicke’s encephalopathy, Mallory-Weiss tear, central pontine myelinolysis, acute tubular necrosis, and fetal growth issues.
-
This question is part of the following fields:
- Gastroenterology/Nutrition
-
00
Correct
00
Incorrect
00
:
00
:
00
Session Time
00
:
00
Average Question Time (
Mins)